marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
CannBioRx Life Sciences Corp. Balance Sheet 2011-2024 | ATNFW
Annual Balance Sheet CannBioRx Life Sciences Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -547 K | - | - | - | - | - | - | - | - |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
5.66 M | 19.7 M | 21.4 M | 3.13 M | 546 K | 208 K | - | - | - | - | - | - |
Total Liabilities |
8.31 M | 23.4 M | - | 7.15 M | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-107 M | -68.7 M | - | 1.07 M | - | - | - | - | - | - | - | - |
Total Assets |
19.7 M | 62.7 M | - | 12.5 M | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | 2.11 M | 547 K | 271 K | 428 K | 67.2 K | - | - | - | - | - |
Book Value |
11.3 M | 39.3 M | - | 5.35 M | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
11.3 M | 39.3 M | 30.3 M | 38.6 M | 5 M | 5 M | 21.9 K | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet CannBioRx Life Sciences Corp.
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
6.74 M | 4.33 M | 4.4 M | 5.39 M | 5.11 M | 6.95 M | 7.78 M | 8.31 M | 8.26 M | 10.6 M | 18.8 M | 23.4 M | 27.9 M | 53.5 M | 37.4 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M | 13.3 M | 7.15 M | 7.15 M | 7.15 M | 4.57 M | 4.57 M | 4.57 M | 4.57 M | 4.23 M | 4.23 M | 4.23 M | 4.23 M | 218 K | 218 K | 218 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-129 M | -128 M | -128 M | -127 M | -126 M | -116 M | -112 M | -107 M | -85.7 M | -64.2 M | -67.1 M | -68.7 M | -69.7 M | -88 M | -64.6 M | -48.4 M | -48.4 M | -48.4 M | -48.4 M | -37.5 M | 1.07 M | 1.07 M | 1.07 M | 1.16 M | 1.16 M | 1.16 M | 1.16 M | 121 K | 121 K | 121 K | 121 K | -3.1 K | -3.1 K | -3.1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
10.5 M | 3.91 M | 3.44 M | 5.26 M | 4.96 M | 13.7 M | 14.9 M | 19.7 M | 34.3 M | 53.4 M | 59.7 M | 62.7 M | 65.1 M | 56.3 M | 60.1 M | 55.5 M | 55.5 M | 55.5 M | 55.5 M | 51.9 M | 12.5 M | 12.5 M | 12.5 M | 118 M | 118 M | 118 M | 118 M | 117 M | 117 M | 117 M | 117 M | 240 K | 240 K | 240 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
195 K | 1.15 M | 676 K | 1.98 M | 2.66 M | 2.01 M | 2.65 M | - | 3.59 M | 1.63 M | 5.67 M | 8.22 M | 11.7 M | 1.84 M | 6.05 M | 2.11 M | 32.7 K | 2.11 M | 2.11 M | 83.4 K | 547 K | 547 K | 547 K | 567 K | 271 K | 271 K | 271 K | 428 K | 428 K | 428 K | 428 K | 67.2 K | 67.2 K | 67.2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
3.73 M | -418 K | -954 K | -128 K | -149 K | 6.72 M | 7.14 M | 11.3 M | 26.1 M | 42.8 M | 40.9 M | 39.3 M | 37.1 M | 2.72 M | 22.7 M | 30.3 M | 30.3 M | 30.3 M | 30.3 M | 38.6 M | 5.35 M | 5.35 M | 5.35 M | 114 M | 114 M | 114 M | 114 M | 113 M | 113 M | 113 M | 113 M | 21.9 K | 21.9 K | 21.9 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
3.73 M | -418 K | -954 K | -128 K | -149 K | 6.72 M | 7.14 M | 11.3 M | 26.1 M | 42.8 M | 40.9 M | 39.3 M | 37.1 M | 2.72 M | 22.7 M | 30.3 M | 30.3 M | 30.3 M | 30.3 M | 38.6 M | 5 M | 5 M | 5 M | -7.68 M | 5 M | 5 M | 5 M | 5 M | 5 M | 5 M | 5 M | 21.9 K | 21.9 K | 21.9 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency